TransCode Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.

About RNAZ

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA. 

CEO
Robert Michael Dudley
CEORobert Michael Dudley
Employees
9
Employees9
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2016
Founded2016
Employees
9
Employees9

RNAZ Key Statistics

Market cap
13.43M
Market cap13.43M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
14.95K
Average volume14.95K
High today
$1.06
High today$1.06
Low today
$1.02
Low today$1.02
Open price
$1.03
Open price$1.03
Volume
1.68K
Volume1.68K
52 Week high
$3.65
52 Week high$3.65
52 Week low
$0.98
52 Week low$0.98

RNAZ Earnings

-$0.36
-$0.07
$0.22
$0.51
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14
ActualExpected Nov 14
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.